|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
K-NF-
B pathway in muscle does not cause insulin resistance1Diabetes and Obesity Research Program, Garvan Institute of Medical Research, Sydney; 2School of Medical Sciences, Faculty of Medicine, and 3St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia
Submitted 17 August 2007 ; accepted in final form 19 November 2007
Insulin resistance of skeletal muscle is a major defect in obesity and type 2 diabetes. Insulin resistance has been associated with a chronic subclinical inflammatory state in epidemiological studies and specifically with activation of the inhibitor
B kinase (I
BK)-nuclear factor-
B (NF-
B) pathway. However, it is unclear whether this pathway plays a role in mediating insulin resistance in muscle in vivo. We separately overexpressed the p65 subunit of NF-
B and I
BKβ in single muscles of rats using in vivo electrotransfer and compared the effects after 1 wk vs. paired contralateral control muscles. A 64% increase in p65 protein (P < 0.001) was sufficient to cause muscle fiber atrophy but had no effect on glucose disposal or glycogen storage in muscle under hyperinsulinemic-euglycemic clamp conditions. Similarly, a 650% increase in I
BKβ expression (P < 0.001) caused a significant reduction in I
B protein but also had no effect on clamp glucose disposal after lipid infusion. In fact, I
BKβ overexpression in particular caused increases in activating tyrosine phosphorylation of insulin receptor substrate-1 (24%; P = 0.02) and serine phosphorylation of Akt (23%; P < 0.001), implying a moderate increase in flux through the insulin signaling cascade. Interestingly, p65 overexpression resulted in a negative feedback reduction of 36% in Toll-like receptor (TLR)-2 (P = 0.03) but not TLR-4 mRNA. In conclusion, activation of the I
BKβ-NF-
B pathway in muscle does not seem to be an important local mediator of insulin resistance.
inhibitor
kinase-nuclear factor-
B pathway; skeletal muscle; Toll-like receptors; in vivo electrotransfer
This article has been cited by other articles:
![]() |
A. M Caricilli, P. H Nascimento, J. R Pauli, D. M L Tsukumo, L. A Velloso, J. B Carvalheira, and M. J A Saad Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet J. Endocrinol., December 1, 2008; 199(3): 399 - 406. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |